| Database ID | Agent | Target | Cancer Type | Detail |
| DB00646 | erlotinib | Epidermal growth factor receptor | advanced cancer with brain metastasis | view |
| DB00647 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced cancer with brain metastasis | view |
| DB00648 | gefitinib | Epidermal growth factor receptor | advanced cancer with brain metastasis | view |
| DB00649 | alectinib | ALK inhibition including activity againstL1196M, G1269A, C1156Y, and F1174Lmutations | advanced cancer with brain metastasis | view |
| DB00650 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced cancer with brain metastasis | view |
| DB00651 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced cancer with brain metastasis | view |
| DB00652 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced cancer with brain metastasis | view |
| DB00653 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced cancer with brain metastasis | view |
| DB00654 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced cancer with brain metastasis | view |
| DB00655 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced cancer with brain metastasis | view |
| DB00656 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced cancer with brain metastasis | view |
| DB00657 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | advanced cancer with brain metastasis | view |
| DB00658 | dabrafenib | BRaf protooncogene serine/threonineprotein kinase | melanoma | view |
| DB00659 | vemurafenib | BRaf protooncogene
serine/threonineprotein kinase | advanced cancer with brain metastasis | view |
| DB00660 | ipilimumab | Cytotoxic Tlymphocyte antigen 4 (CTLA4) | melanoma | view |